FDA approves Wegovy to reduce heart disease and stroke risk
The FDA has approved Wegovy to reduce cardiovascular risk in people with obesity, based on results from Novo Nordisk’s SELECT trial.
Keeping your diabetes kit safe and in one place.
The FDA has approved Wegovy to reduce cardiovascular risk in people with obesity, based on results from Novo Nordisk’s SELECT trial.
Professor Claire Meek at the University of Leicester is leading one of five global research projects receiving part of £1.5 million
Leading experts are calling for glucose monitoring technology – which is currently only available in the UK to people on intensive
New research has identified a genetic variant amongst people of South Asian heritage that may give falsely lower results for HbA1c
A new research initiative is currently seeking volunteers to participate in a pioneering study that aims to investigate the feasibility of
Oxford University researchers are to set up the first UK registry for children and adults at risk of Type 1 diabetes.